Find Products

Embryonic Rat Hypothalamic Cell Lines

This product line is based on a proprietary platform technology which has enabled the creation of a series of immortalized hypothalamic neurons; immortalized from rat embryonic day 18 hypothalamic primary cultures by retroviral transfer of SV40 T-Ag. These cell lines have been found to express an ever expanding array of neuropeptides, enzymatic markers and biologically […]

This product line is based on a proprietary platform technology which has enabled the creation of a series of immortalized hypothalamic neurons; immortalized from rat embryonic day 18 hypothalamic primary cultures by retroviral transfer of SV40 T-Ag. These cell lines have been found to express an ever expanding array of neuropeptides, enzymatic markers and biologically active receptors.
As such, these cell lines enable accurate in-vitro assays for use in the discovery, development and validation of new therapeutics targeted to central-nervous system diseases and disorders, including obesity, stress, and metabolic disorders, amongst others.

Read more +

View Products Enquire Now

Showing all 22 products

Filter by:

Product Units
(rHypoE-11)
CLU205
1 Ml
(rHypoE-13)
CLU206
1 Ml
(rHypoE-15)
CLU207
1 Ml
(rHypoE-16)
CLU208
1 Ml
(rHypoE-18)
CLU209
1 Ml
(rHypoE-19)
CLU210
1 Ml
(rHypoE-20)
CLU211
1 Ml
(rHypoE-21)
CLU212
1 Ml
(rHypoE-22)
CLU213
1 Ml
(rHypoE-23)
CLU214
1 Ml
(rHypoE-24)
CLU215
1 Ml
(rHypoE-25)
CLU216
1 Ml
(rHypoE-27)
CLU217
1 Ml
(rHypoE-28)
CLU218
1 Ml
(rHypoE-29)
CLU219
1 Ml
(rHypoE-30)
CLU220
1 Ml
(rHypoE-31)
CLU221
1 Ml
(rHypoE-33)
CLU222
1 Ml
(rHypoE-6)
CLU201
1 Ml
(rHypoE-7)
CLU202
1 Ml
(rHypoE-8)
CLU203
1 Ml
(rHypoE-9)
CLU204
1 Ml
  • Enquire Now

    We work with a range of suppliers with novel and innovative products sourced from our global partners.

Find Products

We work with a range of suppliers with novel and innovative products sourced from our global partners.

Find Products

Browser Warning

VHBio is not supported on Internet Explorer and will not provide you with the best experience. Please consider switching to a compatible browser such as Microsoft Edge, Google Chrome or Firefox.